FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963949057> ?p ?o ?g. }

• W2963949057 abstract "Nevirapine-based antiretroviral therapy (ART) is one of the limited options in HIV-infected children younger than 3 years old (young children) with tuberculosis (TB) coinfection. To date, there are insufficient data to recommend nevirapine-based therapy during first-line antituberculosis (anti-TB) therapy in young children. We compared nevirapine pharmacokinetics (PK) in HIV-infected young children with and without TB coinfection. In the coinfected group, nevirapine PK was evaluated while on anti-TB therapy and after completing an anti-TB therapy regimen. Of 53 participants, 23 (43%) had TB-HIV coinfection. While the mean difference in nevirapine PK parameters between the two groups was not significant (P > 0.05), 14/23 (61%) of the children with TB-HIV coinfection and 9/30 (30%) with HIV infection had a nevirapine minimum concentration (Cmin) below the proposed target of 3.0 mg/liter (P = 0.03). In multivariate analysis, anti-TB therapy and the CYP2B6 516G>T genotype were joint predictors of nevirapine PK parameters. Differences in nevirapine PK parameters between the two groups were significant in children with CYP2B6 516GG but not the GT or TT genotype. Among 14 TB-HIV-coinfected participants with paired data, the geometric mean Cmin and area under the drug concentration-time curve from time zero to 12 h (AUC0-12) were about 34% lower when patients were taking anti-TB therapy, while the nevirapine apparent oral clearance (CL/F) was about 45% higher. While the induction effect of anti-TB therapy on nevirapine PK in our study was modest, the CYP2B6 genotype-dependent variability in the TB drug regimen effect would complicate any dose adjustment strategy in young children with TB-HIV coinfection. Alternate ART regimens that are more compatible with TB treatment in this age group are needed. (This study has been registered at ClinicalTrials.gov under identifier NCT01699633.)." @default.
• W2963949057 created "2019-07-30" @default.
• W2963949057 creator A5023039183 @default.
• W2963949057 creator A5024906207 @default.
• W2963949057 creator A5032085827 @default.
• W2963949057 creator A5033215111 @default.
• W2963949057 creator A5035478609 @default.
• W2963949057 creator A5037684823 @default.
• W2963949057 creator A5044162218 @default.
• W2963949057 creator A5053945845 @default.
• W2963949057 creator A5055231042 @default.
• W2963949057 creator A5059101690 @default.
• W2963949057 creator A5061865147 @default.
• W2963949057 creator A5072988639 @default.
• W2963949057 creator A5073239264 @default.
• W2963949057 creator A5073438039 @default.
• W2963949057 creator A5087737186 @default.
• W2963949057 creator A5091295123 @default.
• W2963949057 date "2019-10-01" @default.
• W2963949057 modified "2023-10-15" @default.
• W2963949057 title "Effect of First-Line Antituberculosis Therapy on Nevirapine Pharmacokinetics in Children Younger than Three Years Old" @default.
• W2963949057 cites W1981574487 @default.
• W2963949057 cites W1981712752 @default.
• W2963949057 cites W1981884897 @default.
• W2963949057 cites W1988363471 @default.
• W2963949057 cites W2003378262 @default.
• W2963949057 cites W2005041408 @default.
• W2963949057 cites W2013015131 @default.
• W2963949057 cites W2019267779 @default.
• W2963949057 cites W2030021013 @default.
• W2963949057 cites W2031605658 @default.
• W2963949057 cites W2032244821 @default.
• W2963949057 cites W2033925611 @default.
• W2963949057 cites W2035412462 @default.
• W2963949057 cites W2036611705 @default.
• W2963949057 cites W2036809137 @default.
• W2963949057 cites W2051831532 @default.
• W2963949057 cites W2051978736 @default.
• W2963949057 cites W2054209819 @default.
• W2963949057 cites W2063831126 @default.
• W2963949057 cites W2098698934 @default.
• W2963949057 cites W2109136168 @default.
• W2963949057 cites W2109499383 @default.
• W2963949057 cites W2118621462 @default.
• W2963949057 cites W2128266687 @default.
• W2963949057 cites W2132801707 @default.
• W2963949057 cites W2134099620 @default.
• W2963949057 cites W2134294082 @default.
• W2963949057 cites W2154130101 @default.
• W2963949057 cites W2163899436 @default.
• W2963949057 cites W2327049603 @default.
• W2963949057 cites W2329526205 @default.
• W2963949057 cites W2560550631 @default.
• W2963949057 cites W2727390836 @default.
• W2963949057 cites W2745006777 @default.
• W2963949057 cites W2751356128 @default.
• W2963949057 cites W2769797845 @default.
• W2963949057 cites W763515031 @default.
• W2963949057 doi "https://doi.org/10.1128/aac.00839-19" @default.
• W2963949057 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6761507" @default.
• W2963949057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31332062" @default.
• W2963949057 hasPublicationYear "2019" @default.
• W2963949057 type Work @default.
• W2963949057 sameAs 2963949057 @default.
• W2963949057 citedByCount "2" @default.
• W2963949057 countsByYear W29639490572020 @default.
• W2963949057 countsByYear W29639490572021 @default.
• W2963949057 crossrefType "journal-article" @default.
• W2963949057 hasAuthorship W2963949057A5023039183 @default.
• W2963949057 hasAuthorship W2963949057A5024906207 @default.
• W2963949057 hasAuthorship W2963949057A5032085827 @default.
• W2963949057 hasAuthorship W2963949057A5033215111 @default.
• W2963949057 hasAuthorship W2963949057A5035478609 @default.
• W2963949057 hasAuthorship W2963949057A5037684823 @default.
• W2963949057 hasAuthorship W2963949057A5044162218 @default.
• W2963949057 hasAuthorship W2963949057A5053945845 @default.
• W2963949057 hasAuthorship W2963949057A5055231042 @default.
• W2963949057 hasAuthorship W2963949057A5059101690 @default.
• W2963949057 hasAuthorship W2963949057A5061865147 @default.
• W2963949057 hasAuthorship W2963949057A5072988639 @default.
• W2963949057 hasAuthorship W2963949057A5073239264 @default.
• W2963949057 hasAuthorship W2963949057A5073438039 @default.
• W2963949057 hasAuthorship W2963949057A5087737186 @default.
• W2963949057 hasAuthorship W2963949057A5091295123 @default.
• W2963949057 hasBestOaLocation W29639490571 @default.
• W2963949057 hasConcept C112705442 @default.
• W2963949057 hasConcept C126322002 @default.
• W2963949057 hasConcept C142462285 @default.
• W2963949057 hasConcept C142724271 @default.
• W2963949057 hasConcept C203014093 @default.
• W2963949057 hasConcept C22979827 @default.
• W2963949057 hasConcept C2777813720 @default.
• W2963949057 hasConcept C2778335254 @default.
• W2963949057 hasConcept C2779130552 @default.
• W2963949057 hasConcept C2781069245 @default.
• W2963949057 hasConcept C2781413609 @default.
• W2963949057 hasConcept C2993143319 @default.
• W2963949057 hasConcept C3013748606 @default.
• W2963949057 hasConcept C71924100 @default.
• W2963949057 hasConcept C98274493 @default.

• next